IP Library Granted Patent US 7,009,180
Granted Patent B2
US 7,009,180 · App. 10/319,409 · Granted Mar 7, 2006

Pathlength-independent methods for optically determining material composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,009,180
App. No.
10/319,409
Granted
Mar 7, 2006
Kind
B2
Abstract

A method uses spectroscopy to determine an analyte concentration in a sample. The method includes producing an absorbance spectrum of the sample. The method further includes shifting the absorbance spectrum to zero in a wavelength region. The method further includes subtracting a water or other substance contribution from the absorbance spectrum.

Claims (85)

1. A method of measuring concentration of glucose in a fluid sample comprising, in no particular order:

providing a cuvette;

providing a source of electromagnetic radiation that emits radiation through the cuvette;

providing a detector that detects radiation emitted from the source, the detection occurring after the radiation has traveled a pathlength, traveling a pathlength comprising passing at least through the cuvette;

inserting saline reference fluid into the cuvette;

using the saline reference fluid to determine the pathlength;

using the pathlength to determine the correct reference spectrum for sample water absorbance, and calculating the correct reference spectrum for sample water absorbance or selecting the correct reference spectrum for sample water absorbance from among a plurality of stored reference spectra;

using the pathlength to determine the correct reference spectrum for sample protein absorbance, and calculating the correct reference spectrum for sample protein absorbance or selecting the correct reference spectrum for sample protein absorbance from among a plurality of stored reference spectra;

inserting a fluid sample into the cuvette;

emitting a range of wavelengths from the source through the cuvette and the fluid sample;

obtaining total sample absorbance data by measuring, through the range of wavelengths, the amount of radiation that reaches the detector;

subtracting the correct reference water and protein absorbance spectra from the total sample absorbance data; and

using the remaining absorbance spectrum, after the correct reference water and protein absorbance spectra have been subtracted, to determine concentration of glucose in the fluid sample.

2. The method of claim 1 , wherein the emitter emits electromagnetic radiation in the infrared range.

3. The method of claim 1 , wherein the correct reference water absorbance spectra is subtracted from the total sample absorbance data before the correct reference protein absorbance spectra is subtracted from the total sample absorbance data.

4. The method of claim 1 , wherein the pathlength is determined based on water absorbance for wavelengths between approximately 4.5 and approximately 5 micrometers.

5. The method of claim 1 , wherein the range of wavelengths comprises more than one wavelength.

6. The method of claim 1 , wherein the correct water absorbance reference spectrum comprises the absorption rate of water at more than one wavelength for the given pathlength.

7. The method of claim 1 , wherein the correct water absorbance reference spectrum is determined using an absorbance peak at approximately 4.7 micrometers.

8. The method of claim 1 , wherein confirmation that the correct water absorbance reference spectrum has been subtracted is obtained by determination that there is zero residual absorbance in the wavelengths between approximately 4.5 and approximately 5 micrometers.

9. The method of claim 1 , wherein the correct protein absorbance reference spectrum comprises the absorption rate of protein at more than one wavelength for the given pathlength.

10. The method of claim 1 , wherein the correct protein absorbance reference spectrum is determined using an absorbance peak between approximately 7.0 and approximately 7.2 micrometers.

11. The method of claim 1 , wherein the correct protein absorbance reference spectrum is determined using an absorbance peak between approximately 7.9 and approximately 8.1 micrometers.

12. The method of claim 1 , wherein absorbance spectra are obtained using a Fourier-Transform Infrared instrument.

13. The method of claim 1 , wherein the concentration of glucose is determined using an absorbance peak at approximately 9.25 micrometers.

14. The method of claim 1 , wherein the concentration of glucose is determined using an absorbance peak at approximately 9.65 micrometers.

15. A method of measuring concentration of an analyte in a fluid sample comprising, in no particular order:

providing a sample container;

providing a source of electromagnetic radiation that emits radiation through the sample container;

providing a detector of electromagnetic radiation that detects radiation emitted from the source after the radiation has traveled a pathlength, traveling a path length comprising passing at least through the sample container;

inserting a reference fluid into the sample container;

determining the pathlength;

using the pathlength to determine the correct reference spectrum for sample water absorbance;

inserting a fluid sample into the sample container;

emitting at least one wavelength from the source through the sample container and the fluid sample;

obtaining composite sample data by measuring the amount of radiation of the at least one wavelength that reaches the detector;

subtracting the correct water absorbance reference spectrum from the composite sample data; and

using the remaining absorbance spectrum, after the correct water absorbance reference spectrum has been subtracted, to determine concentration of the analyte in the fluid sample.

16. The method of claim 15 , further comprising:

using the pathlength to determine the correct reference spectrum for sample protein absorbance;

subtracting the correct protein absorbance reference spectrum from the composite sample data; and

using the remaining absorbance spectrum, after the correct protein absorbance reference spectrum has been subtracted, to determine concentration of the analyte in the fluid sample.

17. The method of claim 15 , wherein the analyte is Glucose.

18. The method of claim 15 , wherein the sample container is a cuvette.

19. The method of claim 15 , wherein the emitter emits electromagnetic radiation in the infrared range.

20. The method of claim 15 , wherein the pathlength is determined using a fringe pattern of the fluid container when the container is empty.

21. The method of claim 15 , wherein the pathlength is determined by measuring the absorbance of the reference fluid.

22. The method of claim 21 , wherein the pathlength determination is made both before and after composite sample data has been obtained.

23. The method of claim 21 , wherein the reference fluid is water.

24. The method of claim 21 , wherein the reference fluid is saline solution.

25. The method of claim 15 , wherein the pathlength is determined based on water absorbance for a wavelength in the range of approximately 4.5 to approximately 5 micrometers.

26. The method of claim 15 , wherein the range of wavelengths comprises more than one wavelength.

27. The method of claim 15 , wherein the range of wavelengths comprises at least one discreet wavelength.

28. The method of claim 15 , wherein the correct water absorbance reference spectrum comprises the absorption rate of water at more than one wavelength for the given pathlength.

29. The method of claim 15 , wherein the correct water absorbance reference spectrum comprises at least one absorbance value at or near a reference water wavelength.

30. The method of claim 15 , wherein the correct water absorbance reference spectrum is determined using an absorbance peak at approximately 4.7 micrometers.

31. The method of claim 15 , wherein confirmation that the correct water absorbance reference spectrum has been subtracted is obtained by determination that there is zero residual absorbance in the wavelengths between approximately 4.5 and approximately 5 micrometers.

32. The method of claim 15 , wherein the correct protein absorbance reference spectrum comprises the absorption rate of protein at more than one wavelength for the given pathlength.

33. The method of claim 15 , wherein the correct protein absorbance reference spectrum comprises the absorption rate of protein at more than one wavelength for the given pathlength.

34. The method of claim 15 , wherein the correct protein absorbance reference spectrum comprises at least one absorbance value at or near a reference protein wavelength.

35. The method of claim 15 , wherein the correct protein absorbance reference spectrum is determined using an absorbance peak between approximately 7.0 and approximately 7.2 micrometers.

36. The method of claim 15 , wherein the correct protein absorbance reference spectrum is determined using an absorbance peak between approximately 7.9 and approximately 8.1 micrometers.

37. The method of claim 15 , wherein absorbance spectra are obtained using a Fourier-Transform Infrared instrument.

38. The method of claim 15 , wherein the analyte is glucose.

39. The method of claim 38 , wherein the concentration of the analyte is determined using an absorbance peak at approximately 9.25 micrometers.

40. The method of claim 38 , wherein the concentration of the analyte is determined using an absorbance peak at approximately 9.65 micrometers.

41. A method of measuring concentration of an analyte in a fluid sample comprising, in no particular order:

providing a sample container;

providing a source of electromagnetic radiation that emits radiation through the sample container;

providing a detector of electromagnetic radiation that detects radiation emitted from the source after the radiation has traveled a pathlength, traveling a pathlength comprising passing at least through the sample container;

inserting a reference fluid into the sample container;

determining the pathlength;

using the pathlength to determine the correct reference spectrum for sample water absorbance, the reference spectrum for sample water absorbance comprising at least one absorbance value at or near a reference water wavelength;

inserting a fluid sample into the sample container;

emitting at least one wavelength from the source through the sample container and the fluid sample;

obtaining composite sample data by measuring the amount of the at least one wavelength of radiation that reaches the detector; and

subtracting the correct water absorbance reference spectrum from the composite sample data; and

using the remaining absorbance spectrum, after the correct water absorbance reference spectrum has been subtracted, to determine concentration of the analyte in the fluid sample.

42. The method of claim 41 , further comprising:

using the pathlength to determine the correct reference spectrum for sample protein absorbance, the reference spectrum for sample protein absorbance comprising at least one absorbance value at or near a reference protein wavelength;

subtracting the correct protein absorbance reference spectrum from the composite sample data; and

using the remaining absorbance spectrum, after the correct protein absorbance reference spectrum has been subtracted, to determine concentration of the analyte in the fluid sample.

43. The method of claim 41 , wherein at least one of the reference water wavelengths is approximately 4.7 micrometers.

44. The method of claim 41 , wherein at least one of the reference protein wavelengths is approximately 7.1 micrometers.

45. The method of claim 41 , wherein at least one of the reference protein wavelengths is approximately 8.0 micrometers.

Assignments (8)
AMENDED AND RESTATED IP SECURITY AGREEMENT Recorded Feb 28, 2018
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 045469/0948 →
RELEASE OF SECURITY INTEREST Recorded Jan 11, 2017
From: HERCULES TECHNOLOGY II, L.P.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 041344/0534 →
ASSIGNMENT AND RELEASE OF SECURITY INTEREST Recorded Dec 18, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 031847/0600 →
SECURITY AGREEMENT Recorded Dec 13, 2013
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 031815/0377 →
SECURITY AGREEMENT Recorded May 23, 2008
From: OPTISCAN BIOMEDICAL CORPORATION
To: HERCULES TECHNOLOGY II, L.P.
Reel/Frame 020995/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2006
From: WITTE, KENNETH G.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 017646/0210 →
PATENT COLLATERAL ASSIGNMENT Recorded Jun 22, 2005
From: OPTISCAN BIOMEDICAL CORPORATION
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 016172/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2005
From: STERLING, BERNHARD B.; BRAIG, JAMES R.; HARTSTEIN, PHILIP C.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 016169/0638 →